Stefan Braam

Dynamk Capital LLC (Dynamk Capital) is a venture capital firm founded in 2017 by Daniella Kranjac and Mario Kranjac. The firm is headquartered in New York, New York.

Denver Solutions LLC operates as a trusted FDA-registered 503B outsourcing provider of ophthalmology and hospital-based services. It also offers repackaged Avastin service and ON-Q pain relief system fill services. The company was founded in 1926 and is headquartered in Englewood, CO.

Kiniciti is a platform company that invests in and partners with companies to strengthen the cell and gene therapy ecosystem. The company, which is based in New York, NY, was founded by Geoffrey Michael Glass, who has been the CEO since incorporation. Kiniciti is backed by private equity firm Welsh, Carson, Anderson & Stowe (WCAS) and Biospring Partners. The company offers a highly tailored, collaborative, and flexible investment and strategic support model to ensure the promise of cell and gene therapeutics is delivered quickly and safely to patients worldwide. The leadership team includes professionals experienced in investing in and building successful companies across the life sciences sector.

Aptuit LLC engages in the development of pharmaceutical and biotechnological products. Its offerings include drug design and discovery, preclinical biosciences, API development and manufacture, solid state chemistry, solid and oral dosage form development and manufacture, integrated drug discovery and drug development, Aptuit INDiGO, and physical and analytical chemistry services. The company was founded in December 2004 and is headquartered in Greenwich, CT.

Patheon Biologics LLC manufactures, supplies clinical and commercial bulk biologics to the biopharmaceutical industry. The company was founded in 2010 and is headquartered in Jefferson City, MO.

AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark.

AGC Biologics, Inc. develops therapeutic proteins for early clinical trials. The firm offers integrated cGMP manufacturing services using microbial fermentation and mammalian cell culture processes. The company was founded in 2007 and is headquartered in Bothell, WA.

Lucid Scientific, Inc. provides technology services. The company is headquartered in Atlanta, GA.

Alpenglow Biosciences, Inc. engages in the development and production of three-dimensional open-top light-sheet microscope for the improvement of conducting pathology. The company was founded by Steven Buckley, Adam Glaser, Jonathan Liu, Nicholas Reder, and Larry True in 2018 and is headquartered in Seattle, WA.

Part of Bayer AG, Bayer HealthCare is a company that provides medical care and animal health care services. The company is based in Tarrytown, NY.

CellFE, Inc. develops delivery platform to enable engineering of life-saving therapies. The company was founded by Anna Liu and Alla Zamarayeva in 2018 and is headquartered in San Carlos, CA.

Curi Bio, Inc. is engaged in providing drug development services. The company was founded by Elliot Fisher and Deol-Ho Kim and is headquartered in Seattle, WA.

Vernal Biosciences, Inc. is a fully integrated contract development and manufacturing organization (CDMO) that specializes in manufacturing and formulating mRNA and LNP-mRNA. Vernal's focus is on democratizing access to their expertise and unparalleled LNP-platform technologies to accelerate the potential of mRNA. The American company provides comprehensive high purity platform manufacturing solutions for mRNA-based medicines, from research to clinical development. Vernal Biosciences is pioneering the custom development and manufacturing process for a variety of applications including vaccine development, gene replacement, and more. The company was founded in 2021 and is headquartered just outside of an undisclosed location. The company was founded by Cobaugh Christian, who has been the CEO since incorporation.

MaSTherCell SA engages in providing cell therapy manufacturing services. The company was founded in 2011 and is headquartered in Charleroi, Belgium.

Catalent MSTC, Inc. provides full service contract development and manufacturing services (CDMO) for cell therapy companies. It offers process and assay development, quality management, and cGMP cell therapy manufacturing services. The company was incorporated on December 27, 2017 and is headquartered in Dover, DE.

ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium.

The Healthcare Private Equity Association is a non-profit trade association that supports the reputation, knowledge, and relationships of the healthcare private equity community. The non-profit company is based in Needham, MA. The association's member firms are committed to building successful and enduring businesses in the healthcare industry. The company brings industry knowledge, broad networks, and deep expertise to help companies grow, create jobs, and deliver high-quality healthcare. The association's member firms have over $1 trillion in assets under management and have supported the growth of over 1500 healthcare businesses. The company was founded by Jeffrey K. Rhodes, Brian Christopher Miller.

Welsh, Carson, Anderson & Stowe (WCAS) is a private equity firm founded in 1979 by Patrick Welsh, Russ Carson and Bruce Anderson. The firm is headquartered in New York.

Biotechnological Enzymatic Catalyse NV develops, produces and commercializes enzymatic systems for food preservation. It engages in the research, development and manufacturing of antimicrobial products for food safety. The firm's solutions are designed for use in the following: dairy products, fruit and vegetable juices, sauces and dressings and liquid egg products. The company was founded in 1992 and is headquartered in Ghent, Belgium.

The Belgian Venture Capital & Private Equity Association provides equity capital to enterprises not quoted on a stock market. The firm develops new products and technologies to expand working capital, to make acquisitions or to strengthen a company’s balance sheet. The company was founded in 1986 and is headquartered in Brussels, Belgium.

Tibotec-Virco NV develops drugs and individualized disease management products. The firm also offers early stage research programs concentrating on the development of treatments for cancer, hepatitis C, and other infectious diseases. The company also provides HIV drug resistance testing and other analytical services in the United States, Japan, Europe, Canada, and Australia. It has operations in Belgium, North Carolina, Ireland, and the United Kingdom. It was founded in by Paul Stoffels in March, 2001 and is headquartered in Mechelen, Belgium.

CropDesign NV develops traits for cereal crops. It delivers agronomic traits for the global commercial seed markets. The firm focuses on enhancing grain yield in crops such as corn and rice, and increasing biomass of energy crops. Its platform, TraitMill, lows evaluating the effect of genes on the performance of plants under different growing conditions, including drought and low nutrient stress. The company was founded in 1998 and is headquartered in Zwijnaarde, Blgium.

Apitope Technology (Bristol) Ltd. is a European biotech company developing therapeutic vaccines for treating autoimmune and allergic diseases, including multiple sclerosis, Type 1 diabetes, Graves' disease, allergies and organ transplant rejection. The team at Apitope is developing potential therapies intended to selectively treat the underlying cause of a range of autoimmune diseases rather than simply treat the disease symptoms or non-specifically suppress the whole immune system. Apitope's approach is based on well-established scientific evidence published in leading scientific journals showing that soluble, synthetic peptides can selectively suppress abnormal immune responses and reinstate the normal immune balance and thereby, tolerance. The firm's strategy is to position itself as a significant player in the therapeutic peptide space and make it a partner of choice for pharmaceutical companies keen to develop disease modifiers for autoimmune conditions. It has a highly experienced senior management team, with a proven track record in discovering and developing innovative compounds. The company's lead product candidate is under investigation for the potential treatment of multiple sclerosis and is currently in Phase I clinical development. It is partnered with Merck-Serono (a division of Merck KGaA, Darmstadt, Germany), one of the leading companies in the development and marketing of MS therapies.

ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands.

Vesalius Biocapital Partners SARL (Vesalius Biocapital Partners) is an independent venture capital firm founded in 2007 by Stéphane Verdood. The firm is headquartered in Luxembourg.

Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain.

PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Newton Biocapital Partners SPRL is an Independent Venture Capital firm founded in 2017 by Alain Parthoens. Newton Biocapital Partners SPRL is headquartered in Woluwe-Saint-Pierre.

EPICS Therapeutics SA engages in the development of therapeutic solutions for cancer. The company was founded by Jean Combalbert, Alain Parthoens and Francois Fuks on February 20, 2018 and is headquartered in Charleroi, Belgium.